@oren_rom

Associate Dean for Basic and Translational Research, LSU Health Shreveport

lsuhs.edu/departments/school-of-medicine/pathology/research/rom-lab
Joined May 2021
  • Tweets332
  • Following273
  • Followers365
17Media
Targeting lipidated amino acid deficiency mitigates fibrosis via a PPARα/CCL2 axis in #MASH models @jclinicalinvest jci.org/articles/view/204511
1
12
27
1,029
Ma & colleagues found that #endocytic membrane trafficking is essential for #macrophage-mediated #inflammatory responses in #atherosclerosis. Learn more at ahajrnls.org/43Sv1fJ @BishuangC @kovacic_jason @Art_Yurdagul @oren_rom
8
17
1,823
Many thanks, Bruno @Brunorm84 for sharing our work!
Bruno Ramos-Molina, PhD@Brunorm847 Dec 2025
Sex-based multiomics analysis uncovers metabolic and molecular mediators linking #MASH and atherosclerosis @JHEP_Reports jhep-reports.eu/article/S258…
1
1
11
635
We’re hiring a Postdoctoral Fellow! Focus: Mitochondria, Ca²⁺ signaling & protein QC in heart failure. Looking for expertise in iPSC culture, CRISPR gene editing & human organoids. Apply: [email protected] aah.wd5.myworkdayjobs.com/en…
🤖 Made with AI
1
16
1
43
7,988
👇👇Check out our new paper on #SAH in @atvbahajournals We found that targeting neutrophil integrin α9 improves long-term recovery by reducing inflammation and enhancing #Efferocytosis. Congratulations to the incredible team, especially first author Dr. Kaur for this study!
ATVB: An AHA Journal@atvbahajournals4 Aug 2025
A new study from @nirav_dhanesha lab shows that neutrophil integrin α9 impairs efferocytosis and worsens long-term recovery after subarachnoid hemorrhage. @A_WayneOrr @Rajesh_Mohandas @Art_Yurdagul @alf_nobel @oren_rom @Nirav_Dhanesha ahajrnls.org/4lT7jY2
6
3
1
37
2,604
A new study from @nirav_dhanesha lab shows that neutrophil integrin α9 impairs efferocytosis and worsens long-term recovery after subarachnoid hemorrhage. @A_WayneOrr @Rajesh_Mohandas @Art_Yurdagul @alf_nobel @oren_rom @Nirav_Dhanesha ahajrnls.org/4lT7jY2
6
1
17
3,996
Congratulations, Nick! Well-deserved!
Stanford Vascular@StanfordVasc21 Jul 2025
🏅 Congratulations to Dr. @NickLeeper78 on receiving the 2025 ATVB Special Recognition Award in Arteriosclerosis from @American_Heart! Dr. Leeper will be honored at #AHA2025 with the award in New Orleans this November. 🔗 Read the full story: vascular.stanford.edu/news/n…
2
6
293
🏅 Congratulations to Dr. @NickLeeper78 on receiving the 2025 ATVB Special Recognition Award in Arteriosclerosis from @American_Heart! Dr. Leeper will be honored at #AHA2025 with the award in New Orleans this November. 🔗 Read the full story: vascular.stanford.edu/news/n…
5
9
4
48
5,983
Congratulations, Bishuang! Very exciting! Wishing you all the best at UCLA!
Bishuang Cai@BishuangC16 Jul 2025
Hi friends, a quick update: our lab will be relocating to the Department of Medicine at UCLA in early August. We will miss our fiends and collaborators at ISMMS. Thank you to the ISMMS community for all the support over the past years:)
3
302
Hi friends, a quick update: our lab will be relocating to the Department of Medicine at UCLA in early August. We will miss our fiends and collaborators at ISMMS. Thank you to the ISMMS community for all the support over the past years:)
17
3
1
59
5,074
Great work, Ada! Massive congratulations!!
AdaWeinstock@AWeinstock11 Jul 2025
We all know that weight loss in obesity is good- but why does it help? And why is weight regain afterward harmful? 🤔 Excited to announce our new paper is finally out in @JClinicalInvest! 🚀👇 jci.org/articles/view/172198
1
1
9
623
Oren Rom retweeted
Jim Zhai@ZhaiJim28 Jun 2025
We are recruiting a neuropathologist at #LSU Shreveport. Our group growing rapidly! Since 08/23, 10 faculties were recruited, 7 pathologists 3 scientists. Clinical service, education, and research, all are going very strong! Join us and aim high! #pathology #pathologists
11
35
3,419
Great news! Congratulations, Nick! Well-deserved!
Nick Leeper@NickLeeper7831 May 2025
Thank you so much for this announcement. Very fortunate to have received this award and for the opportunity to work on what we believe to be a very important problem. Thank you to the NIH for supporting this work and to the team who is pursuing these studies at the bench.
5
311
Great news, Jesse! Huge congratulations! Very well-deserved!
Jesse Williams Lab@Lab__Williams16 May 2025
Promoted to Associate Professor with tenure, University of Minnesota Medical School! 🎉🍾 @UMN_IBP @CFI_UMN
7
372
Promoted to Associate Professor with tenure, University of Minnesota Medical School! 🎉🍾 @UMN_IBP @CFI_UMN
24
3
3
116
6,135
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis dlvr.it/TKdk3c
15
89
4,595
LSU Health Shreveport honors 10 faculty with Research Excellence Awards trib.al/3D6KIZb

LSU Health Shreveport honors 10 faculty with Research Excellence Awards

“It was an inspiring event and the perfect opportunity to reflect on these accomplishments and look forward to what the future of research at LSU Health Shreveport holds as our institution re…

ktalnews.com
1
3
203
Is IDOL an Ideal Target for Treating Atherosclerosis? | Arteriosclerosis, Thrombosis, and Vascular Biology ahajournals.org/doi/full/10.…
2
6
50
2,901
#STROKE: Uric acid supplementation provides cerebroprotection across different animal species, sex, age, and comorbidities. #AHAJournals @ChauhanLab @Nirav_Dhanesha ahajournals.org/doi/full/10.…
Graphic abstract in Patel and Kumskova et al.

ALT Graphic abstract in Patel and Kumskova et al.

1
15
2
24
6,713
Happy to share our recent study published @Cell_Metabolism showing a new cholesterol metabolism regulator EHBP1 in MASH led by Dr. Fanglin Ma. This collaborative effort included @xiaobowang @oren_rom @Art_Yurdagul @SammiShuang @xhuang1983, Liheng, Susan, Paola, Scott and others!
Cell Metabolism@Cell_Metabolism26 Feb 2025
New! Online now: EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis dlvr.it/TJCT6l
16
7
2
63
5,312
Load more